勘误：希腊中重度斑块状银屑病新患者和现有患者的年度生物治疗费用[更正]
Erratum: Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum].
出版信息
Clinicoecon Outcomes Res. 2015 Mar 17;7:161. doi: 10.2147/CEOR.S82058. eCollection 2015.
Abstract
[This corrects the article on p. 73 in vol. 7, PMID: 25609988.].
摘要
[本文更正了第7卷第73页上的文章，PMID: 25609988。]
相似文献
1
Erratum: Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum].勘误：希腊中重度斑块状银屑病新患者和现有患者的年度生物治疗费用[更正]
Clinicoecon Outcomes Res. 2015 Mar 17;7:161. doi: 10.2147/CEOR.S82058. eCollection 2015.
2
Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.希腊中重度斑块状银屑病新患者和现有患者的年度生物治疗费用。
Clinicoecon Outcomes Res. 2015 Jan 8;7:73-83. doi: 10.2147/CEOR.S75263. eCollection 2015.
3
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
4
Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.降低希腊斑块状银屑病局部和全身治疗的患者自付费用水平，作为基于证据的可持续药品政策变革的一个案例。
J Med Econ. 2016 Nov;19(11):1021-1026. doi: 10.1080/13696998.2016.1192547. Epub 2016 Jun 3.
5
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.布罗达单抗治疗中重度斑块状银屑病对美国商业健康保险计划的预算影响。
J Med Econ. 2018 May;21(5):537-541. doi: 10.1080/13696998.2018.1431920. Epub 2018 Feb 2.
6
Erratum: Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections [Corrigendum].勘误：替考拉宁治疗中国中重度革兰氏阳性菌感染患者的给药方案、谷浓度、疗效及安全性关系的回顾性分析 [更正]
Infect Drug Resist. 2019 Feb 14;12:431. doi: 10.2147/IDR.S204540. eCollection 2019.
7
A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.一项多中心、前瞻性、观察性研究，考察了在希腊常规护理环境中，接受英夫利昔单抗治疗的中重度斑块型银屑病患者，BMI 和腰围等危险因素对生活质量改善和临床应答的影响。
J Eur Acad Dermatol Venereol. 2018 May;32(5):768-775. doi: 10.1111/jdv.14802.
8
Erratum: How does cognitive dissonance influence the sunk cost effect? [Corrigendum].勘误：认知失调如何影响沉没成本效应？[勘误说明]
Psychol Res Behav Manag. 2018 Apr 3;11:79. doi: 10.2147/PRBM.S169092. eCollection 2018.
9
Erratum: Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum].勘误：微创骶髂关节融合术的成本效益[更正]。
Clinicoecon Outcomes Res. 2016 Jun 27;8:305. doi: 10.2147/CEOR.S107803. eCollection 2016.
10
Erratum: Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE [Corrigendum].勘误：沙美特罗/丙酸氟替卡松50/250联合噻托溴铵三联疗法与单独治疗相比可改善中重度日本慢性阻塞性肺疾病患者的肺功能：一项随机对照试验——三联治疗后气道比传导率的评估[勘误]
Int J Chron Obstruct Pulmon Dis. 2016 May 17;11:1031-1033. doi: 10.2147/COPD.S108620. eCollection 2016.
Zotero 插件